1. Home
  2. GLMD vs SANW Comparison

GLMD vs SANW Comparison

Compare GLMD & SANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • SANW
  • Stock Information
  • Founded
  • GLMD 2000
  • SANW 1980
  • Country
  • GLMD Israel
  • SANW United States
  • Employees
  • GLMD N/A
  • SANW N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • SANW Farming/Seeds/Milling
  • Sector
  • GLMD Health Care
  • SANW Consumer Staples
  • Exchange
  • GLMD Nasdaq
  • SANW Nasdaq
  • Market Cap
  • GLMD 4.6M
  • SANW 16.1M
  • IPO Year
  • GLMD 2014
  • SANW 2010
  • Fundamental
  • Price
  • GLMD $3.04
  • SANW N/A
  • Analyst Decision
  • GLMD
  • SANW Strong Buy
  • Analyst Count
  • GLMD 0
  • SANW 1
  • Target Price
  • GLMD N/A
  • SANW $35.00
  • AVG Volume (30 Days)
  • GLMD 45.4K
  • SANW 60.1K
  • Earning Date
  • GLMD 01-03-2025
  • SANW 02-12-2025
  • Dividend Yield
  • GLMD N/A
  • SANW N/A
  • EPS Growth
  • GLMD N/A
  • SANW N/A
  • EPS
  • GLMD N/A
  • SANW N/A
  • Revenue
  • GLMD N/A
  • SANW $57,993,775.00
  • Revenue This Year
  • GLMD N/A
  • SANW N/A
  • Revenue Next Year
  • GLMD N/A
  • SANW $9.92
  • P/E Ratio
  • GLMD N/A
  • SANW N/A
  • Revenue Growth
  • GLMD N/A
  • SANW N/A
  • 52 Week Low
  • GLMD $2.56
  • SANW $2.10
  • 52 Week High
  • GLMD $23.80
  • SANW $14.25
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 49.68
  • SANW 52.65
  • Support Level
  • GLMD $2.81
  • SANW $5.48
  • Resistance Level
  • GLMD $3.35
  • SANW $6.57
  • Average True Range (ATR)
  • GLMD 0.26
  • SANW 0.64
  • MACD
  • GLMD 0.05
  • SANW -0.09
  • Stochastic Oscillator
  • GLMD 57.83
  • SANW 47.87

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

Share on Social Networks: